Is a complete OVID research report available?

No complete published report is available for Ovid Therapeutics Inc. (OVID) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Ovid Therapeutics Inc. (OVID)

NASDAQ: OVID · USD

$2.33

-0.07 (-2.9%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-25 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first OVID analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	434.9M
Revenue (ttm)	7.1M
Net income (ttm)	-24.1M
EPS (ttm)	-$0.27
Shares out	186.6M
Volume	984,942
Beta	0.19
Price target	$5.47	+134.8%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 7.1M
Net income (ttm): -24.1M
EPS (ttm): -$0.27
Market cap: 434.9M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All OVID indicators

Market & fundamental data

Available fields

203

Groups with data

Currency

USD

Showing 203 of 203 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001636651
Company name	Ovid Therapeutics Inc.
Country	United States
Country code	US
Cusip	690469101
Employees	23
Employees Change	-17%
Employees Change Percent	-42.5
Enterprise value	$282.3M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2017-05-05
Isin	US6904691010
Last refreshed	2026-07-25
Market cap	$434.9M
Market cap category	Small-Cap
Price	$2.33
Price currency	USD
Rev Per Employee	309,652.17x
Sector	Healthcare
Sector PE	44.8
Sector PE Fwd	23.64
Sic	2834
Symbol	OVID
Website	https://www.ovidrx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-5.54%
EV Sales Forward	2,209.61x
EV/Sales	39.64x
FCF yield	-9.65%
P/B ratio	1.97x
P/S ratio	61.06x
PS Forward	3,403.28x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-670.25%
EBITDA Margin	-667.9%
Gross margin	100%
Gross Profit	$7.1M
Gross Profit Growth	1,199.64%
Gross Profit Growth3 Y	286.47%
Gross Profit Growth5 Y	-49.69%
Net Income	$-24.1M
Net Income Growth Years	3%
Pretax Margin	-339.33%
Profit Per Employee	$-1M
ROA	-19.66
Roa5y	-7.84
ROCE	-22.74
ROE	-18.77
Roe5y	-4.74
ROIC	-74.21

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	233.13%
Cagr3y	-13.17%
Cagr5y	-9.03%
EPS Growth Quarters	3
EPS Growth Years	3
Revenue Growth	1,199.64x
Revenue Growth Years	2x
Revenue Growth3 Y	286.47x
Revenue Growth5 Y	-49.69x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.05
Assets	$225.6M
Cash	$155.5M
Current Assets	$160.1M
Current Liabilities	$15.7M
Debt	$13.1M
Debt Equity	$0.07
Equity	$198.3M
Liabilities	$27.4M
Long Term Assets	$65.5M
Long Term Liabilities	$11.6M
Net Cash	$152.5M
Net Cash By Market Cap	$35.07
Net Cash Growth	433.95%
Net Debt Equity	$-0.77
Tangible Book Value	$198.3M
Tangible Book Value Per Share	$1.19
WACC	5.13

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	10.17
Net Working Capital	$-9.7M
Quick ratio	9.88
Working Capital	$144.4M
Working Capital Turnover	$0.08

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-26.81%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	232.86%
200-day SMA	2.02
3Y total return	-34.55%
50-day SMA	2.48
50-day SMA vs 200-day SMA	50over200
5Y total return	-37.7%
All Time High	15.93
All Time High Change	-85.37%
All Time High Date	2017-05-18
All Time Low	0.24
All Time Low Change	860.82%
All Time Low Date	2025-04-09
ATR	0.16
Beta	0.19
Beta1y	1.73
Beta2y	2.22
Ch YTD	42.95
High	2.4
High52	3.11
High52 Date	2026-04-09
High52ch	-24.96%
Low	2.31
Low52	0.48
Low52 Date	2025-08-04
Low52ch	390.53%
Ma50ch	-6.01%
Price vs 200-day SMA	15.46%
RSI	42.26
RSI Monthly	57.14
RSI Weekly	52.38
Sharpe ratio	1.58x
Sortino ratio	3.15
Total Return	-26.81%
Tr YTD	42.95
Tr1m	0.43%
Tr1w	-4.51%
Tr3m	-13.06%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	10
Analyst Count Top	6
Analyst Price Target Top	$5
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.1
Earnings Revenue Estimate	30,000x
Earnings Revenue Estimate Growth	-99.52x
Operating Income	$-48.3M
Operating margin	-678.7
Price target	$5.47
Price Target Change	$135
Price Target Change Top	$115

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	154,024,768%
Float Percent	82.53%
Shares Insiders	2.29%
Shares Institutions	55.17%
Shares Out	186,640,102
Shares Qo Q	66.73%
Shares Yo Y	26.81%
Short Float	14.28%
Short Ratio	5.91
Short Shares	11.79

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-46.5M
Average Volume	2,856,458.55x
Bv Per Share	1.19
Ch1m	0.43
Ch1w	-4.51
Ch1y	232.9
Ch3m	-13.06
Ch3y	-34.55
Ch5y	-37.7
Ch6m	37.87
Change	-2.92%
Change From Open	-2.92
Close	2.4
Days Gap	0
Depreciation Amortization	167,000
Dollar Volume	2,294,914.9
Earnings Date	2026-08-12
Earnings Time	bmo
EBIT	$-47.7M
EBITDA	$-47.6M
EPS	$-0.27
F Score	2
FCF	$-42M
FCF EV Yield	-14.86x
FCF Per Share	$-0.22
Financing CF	164,176,000
Fiscal Year End	December
Founded	2,014
Investing CF	-49,006,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-12
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-18
Ma150	2.19
Ma150ch	6.54%
Ma20	2.53
Ma20ch	-7.98%
Net CF	72,928,000
Next Earnings Date	2026-08-12
Open	2.4
Optionable	Yes
Position In Range	22.22
Post Close	2.33
Postmarket Change Percent	1.29
Postmarket Price	$2.36
Ppne	11,515,000
Price Date	2026-07-24
Ptbv Ratio	2.19
Relative Volume	0.34x
Revenue	7,122,000x
SBC By Revenue	64.15x
Share Based Comp	4,569,000
Tr6m	37.87%
Us State	New York
Volume	984,942
Z Score	0.41

Ovid Therapeutics Inc. (OVID)

Coverage state: Market snapshot only — no published research

Generate the first OVID analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · OVID

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All OVID indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on OVID

Frequently asked questions